The global market for Friedreich Ataxia Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Friedreich Ataxia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Friedreich Ataxia Drug.

The Friedreich Ataxia Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Friedreich Ataxia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Friedreich Ataxia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Friedreich Ataxia Drug Market Report

Report Metric	Details
Report Name	Friedreich Ataxia Drug Market
CAGR	5%
Segment by Type	ADVM-063 AGIL-FA BHV-4157 BVA-202 Others
Segment by Application	Clinic Hospital Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Adverum Biotechnologies Inc, BioMarin Pharmaceutical Inc., Biovista Inc., Cardero Therapeutics Inc, Catabasis Pharmaceuticals, Inc., Forward Pharma A/S, Ixchel Pharma LLC, Pfizer Inc, ProQR Therapeutics NV, RaNA Therapeutics Inc, Reata Pharmaceuticals Inc, Retrotope Inc, Takeda, STATegics Inc, Voyager Therapeutics Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Friedreich Ataxia Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Friedreich Ataxia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Friedreich Ataxia Drug Market report?

Ans: The main players in the Friedreich Ataxia Drug Market are Adverum Biotechnologies Inc, BioMarin Pharmaceutical Inc., Biovista Inc., Cardero Therapeutics Inc, Catabasis Pharmaceuticals, Inc., Forward Pharma A/S, Ixchel Pharma LLC, Pfizer Inc, ProQR Therapeutics NV, RaNA Therapeutics Inc, Reata Pharmaceuticals Inc, Retrotope Inc, Takeda, STATegics Inc, Voyager Therapeutics Inc

What are the Application segmentation covered in the Friedreich Ataxia Drug Market report?

Ans: The Applications covered in the Friedreich Ataxia Drug Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Friedreich Ataxia Drug Market report?

Ans: The Types covered in the Friedreich Ataxia Drug Market report are ADVM-063, AGIL-FA, BHV-4157, BVA-202, Others

1 Friedreich Ataxia Drug Market Overview

1.1 Product Definition

1.2 Friedreich Ataxia Drug by Type

1.2.1 Global Friedreich Ataxia Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 ADVM-063

1.2.3 AGIL-FA

1.2.4 BHV-4157

1.2.5 BVA-202

1.2.6 Others

1.3 Friedreich Ataxia Drug by Application

1.3.1 Global Friedreich Ataxia Drug Market Value by Application (2024 VS 2031)

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Friedreich Ataxia Drug Market Size Estimates and Forecasts

1.4.1 Global Friedreich Ataxia Drug Revenue 2020-2031

1.4.2 Global Friedreich Ataxia Drug Sales 2020-2031

1.4.3 Global Friedreich Ataxia Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Friedreich Ataxia Drug Market Competition by Manufacturers

2.1 Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Friedreich Ataxia Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Friedreich Ataxia Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Friedreich Ataxia Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Friedreich Ataxia Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Friedreich Ataxia Drug, Product Type & Application

2.7 Global Key Manufacturers of Friedreich Ataxia Drug, Date of Enter into This Industry

2.8 Global Friedreich Ataxia Drug Market Competitive Situation and Trends

2.8.1 Global Friedreich Ataxia Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Friedreich Ataxia Drug Players Market Share by Revenue

2.8.3 Global Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Friedreich Ataxia Drug Market Scenario by Region

3.1 Global Friedreich Ataxia Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Friedreich Ataxia Drug Sales by Region: 2020-2031

3.2.1 Global Friedreich Ataxia Drug Sales by Region: 2020-2025

3.2.2 Global Friedreich Ataxia Drug Sales by Region: 2026-2031

3.3 Global Friedreich Ataxia Drug Revenue by Region: 2020-2031

3.3.1 Global Friedreich Ataxia Drug Revenue by Region: 2020-2025

3.3.2 Global Friedreich Ataxia Drug Revenue by Region: 2026-2031

3.4 North America Friedreich Ataxia Drug Market Facts & Figures by Country

3.4.1 North America Friedreich Ataxia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Friedreich Ataxia Drug Sales by Country (2020-2031)

3.4.3 North America Friedreich Ataxia Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Friedreich Ataxia Drug Market Facts & Figures by Country

3.5.1 Europe Friedreich Ataxia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Friedreich Ataxia Drug Sales by Country (2020-2031)

3.5.3 Europe Friedreich Ataxia Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Friedreich Ataxia Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Friedreich Ataxia Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Friedreich Ataxia Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Friedreich Ataxia Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Friedreich Ataxia Drug Market Facts & Figures by Country

3.7.1 Latin America Friedreich Ataxia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Friedreich Ataxia Drug Sales by Country (2020-2031)

3.7.3 Latin America Friedreich Ataxia Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Friedreich Ataxia Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Friedreich Ataxia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Friedreich Ataxia Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Friedreich Ataxia Drug Sales by Type (2020-2031)

4.1.1 Global Friedreich Ataxia Drug Sales by Type (2020-2025)

4.1.2 Global Friedreich Ataxia Drug Sales by Type (2026-2031)

4.1.3 Global Friedreich Ataxia Drug Sales Market Share by Type (2020-2031)

4.2 Global Friedreich Ataxia Drug Revenue by Type (2020-2031)

4.2.1 Global Friedreich Ataxia Drug Revenue by Type (2020-2025)

4.2.2 Global Friedreich Ataxia Drug Revenue by Type (2026-2031)

4.2.3 Global Friedreich Ataxia Drug Revenue Market Share by Type (2020-2031)

4.3 Global Friedreich Ataxia Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Friedreich Ataxia Drug Sales by Application (2020-2031)

5.1.1 Global Friedreich Ataxia Drug Sales by Application (2020-2025)

5.1.2 Global Friedreich Ataxia Drug Sales by Application (2026-2031)

5.1.3 Global Friedreich Ataxia Drug Sales Market Share by Application (2020-2031)

5.2 Global Friedreich Ataxia Drug Revenue by Application (2020-2031)

5.2.1 Global Friedreich Ataxia Drug Revenue by Application (2020-2025)

5.2.2 Global Friedreich Ataxia Drug Revenue by Application (2026-2031)

5.2.3 Global Friedreich Ataxia Drug Revenue Market Share by Application (2020-2031)

5.3 Global Friedreich Ataxia Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Adverum Biotechnologies Inc

6.1.1 Adverum Biotechnologies Inc Company Information

6.1.2 Adverum Biotechnologies Inc Description and Business Overview

6.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Portfolio

6.1.5 Adverum Biotechnologies Inc Recent Developments/Updates

6.2 BioMarin Pharmaceutical Inc.

6.2.1 BioMarin Pharmaceutical Inc. Company Information

6.2.2 BioMarin Pharmaceutical Inc. Description and Business Overview

6.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Portfolio

6.2.5 BioMarin Pharmaceutical Inc. Recent Developments/Updates

6.3 Biovista Inc.

6.3.1 Biovista Inc. Company Information

6.3.2 Biovista Inc. Description and Business Overview

6.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Biovista Inc. Friedreich Ataxia Drug Product Portfolio

6.3.5 Biovista Inc. Recent Developments/Updates

6.4 Cardero Therapeutics Inc

6.4.1 Cardero Therapeutics Inc Company Information

6.4.2 Cardero Therapeutics Inc Description and Business Overview

6.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Product Portfolio

6.4.5 Cardero Therapeutics Inc Recent Developments/Updates

6.5 Catabasis Pharmaceuticals, Inc.

6.5.1 Catabasis Pharmaceuticals, Inc. Company Information

6.5.2 Catabasis Pharmaceuticals, Inc. Description and Business Overview

6.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Portfolio

6.5.5 Catabasis Pharmaceuticals, Inc. Recent Developments/Updates

6.6 Forward Pharma A/S

6.6.1 Forward Pharma A/S Company Information

6.6.2 Forward Pharma A/S Description and Business Overview

6.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Forward Pharma A/S Friedreich Ataxia Drug Product Portfolio

6.6.5 Forward Pharma A/S Recent Developments/Updates

6.7 Ixchel Pharma LLC

6.7.1 Ixchel Pharma LLC Company Information

6.7.2 Ixchel Pharma LLC Description and Business Overview

6.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Product Portfolio

6.7.5 Ixchel Pharma LLC Recent Developments/Updates

6.8 Pfizer Inc

6.8.1 Pfizer Inc Company Information

6.8.2 Pfizer Inc Description and Business Overview

6.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Pfizer Inc Friedreich Ataxia Drug Product Portfolio

6.8.5 Pfizer Inc Recent Developments/Updates

6.9 ProQR Therapeutics NV

6.9.1 ProQR Therapeutics NV Company Information

6.9.2 ProQR Therapeutics NV Description and Business Overview

6.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Product Portfolio

6.9.5 ProQR Therapeutics NV Recent Developments/Updates

6.10 RaNA Therapeutics Inc

6.10.1 RaNA Therapeutics Inc Company Information

6.10.2 RaNA Therapeutics Inc Description and Business Overview

6.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Product Portfolio

6.10.5 RaNA Therapeutics Inc Recent Developments/Updates

6.11 Reata Pharmaceuticals Inc

6.11.1 Reata Pharmaceuticals Inc Company Information

6.11.2 Reata Pharmaceuticals Inc Description and Business Overview

6.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Portfolio

6.11.5 Reata Pharmaceuticals Inc Recent Developments/Updates

6.12 Retrotope Inc

6.12.1 Retrotope Inc Company Information

6.12.2 Retrotope Inc Description and Business Overview

6.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Retrotope Inc Friedreich Ataxia Drug Product Portfolio

6.12.5 Retrotope Inc Recent Developments/Updates

6.13 Takeda

6.13.1 Takeda Company Information

6.13.2 Takeda Description and Business Overview

6.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Takeda Friedreich Ataxia Drug Product Portfolio

6.13.5 Takeda Recent Developments/Updates

6.14 STATegics Inc

6.14.1 STATegics Inc Company Information

6.14.2 STATegics Inc Description and Business Overview

6.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.14.4 STATegics Inc Friedreich Ataxia Drug Product Portfolio

6.14.5 STATegics Inc Recent Developments/Updates

6.15 Voyager Therapeutics Inc

6.15.1 Voyager Therapeutics Inc Company Information

6.15.2 Voyager Therapeutics Inc Description and Business Overview

6.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Product Portfolio

6.15.5 Voyager Therapeutics Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Friedreich Ataxia Drug Industry Chain Analysis

7.2 Friedreich Ataxia Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Friedreich Ataxia Drug Production Mode & Process Analysis

7.4 Friedreich Ataxia Drug Sales and Marketing

7.4.1 Friedreich Ataxia Drug Sales Channels

7.4.2 Friedreich Ataxia Drug Distributors

7.5 Friedreich Ataxia Drug Customer Analysis

8 Friedreich Ataxia Drug Market Dynamics

8.1 Friedreich Ataxia Drug Industry Trends

8.2 Friedreich Ataxia Drug Market Drivers

8.3 Friedreich Ataxia Drug Market Challenges

8.4 Friedreich Ataxia Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Adverum Biotechnologies Inc

BioMarin Pharmaceutical Inc

Biovista Inc

Cardero Therapeutics Inc

Catabasis Pharmaceuticals Inc

Forward Pharma A S

Ixchel Pharma LLC

Pfizer Inc

ProQR Therapeutics NV

RaNA Therapeutics Inc

Reata Pharmaceuticals Inc

Retrotope Inc

Takeda

STATegics Inc

Voyager Therapeutics Inc

List of Tables

Table 1. Global Friedreich Ataxia Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Friedreich Ataxia Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Friedreich Ataxia Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Friedreich Ataxia Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Friedreich Ataxia Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Friedreich Ataxia Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Friedreich Ataxia Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Friedreich Ataxia Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Friedreich Ataxia Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Friedreich Ataxia Drug, Product Type & Application

Table 12. Global Key Manufacturers of Friedreich Ataxia Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Friedreich Ataxia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Friedreich Ataxia Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Friedreich Ataxia Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Friedreich Ataxia Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Friedreich Ataxia Drug Sales Market Share by Region (2020-2025)

Table 19. Global Friedreich Ataxia Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Friedreich Ataxia Drug Sales Market Share by Region (2026-2031)

Table 21. Global Friedreich Ataxia Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Friedreich Ataxia Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Friedreich Ataxia Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Friedreich Ataxia Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Friedreich Ataxia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Friedreich Ataxia Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Friedreich Ataxia Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Friedreich Ataxia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Friedreich Ataxia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Friedreich Ataxia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Friedreich Ataxia Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Friedreich Ataxia Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Friedreich Ataxia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Friedreich Ataxia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Friedreich Ataxia Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Friedreich Ataxia Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Friedreich Ataxia Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Friedreich Ataxia Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Friedreich Ataxia Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Friedreich Ataxia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Friedreich Ataxia Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Friedreich Ataxia Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Friedreich Ataxia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Friedreich Ataxia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Friedreich Ataxia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Friedreich Ataxia Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Friedreich Ataxia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Friedreich Ataxia Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Friedreich Ataxia Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Friedreich Ataxia Drug Sales Market Share by Type (2020-2025)

Table 53. Global Friedreich Ataxia Drug Sales Market Share by Type (2026-2031)

Table 54. Global Friedreich Ataxia Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Friedreich Ataxia Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Friedreich Ataxia Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Friedreich Ataxia Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Friedreich Ataxia Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Friedreich Ataxia Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Friedreich Ataxia Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Friedreich Ataxia Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Friedreich Ataxia Drug Sales Market Share by Application (2020-2025)

Table 63. Global Friedreich Ataxia Drug Sales Market Share by Application (2026-2031)

Table 64. Global Friedreich Ataxia Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Friedreich Ataxia Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Friedreich Ataxia Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Friedreich Ataxia Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Friedreich Ataxia Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Friedreich Ataxia Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. Adverum Biotechnologies Inc Company Information

Table 71. Adverum Biotechnologies Inc Description and Business Overview

Table 72. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product

Table 74. Adverum Biotechnologies Inc Recent Developments/Updates

Table 75. BioMarin Pharmaceutical Inc. Company Information

Table 76. BioMarin Pharmaceutical Inc. Description and Business Overview

Table 77. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product

Table 79. BioMarin Pharmaceutical Inc. Recent Developments/Updates

Table 80. Biovista Inc. Company Information

Table 81. Biovista Inc. Description and Business Overview

Table 82. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Biovista Inc. Friedreich Ataxia Drug Product

Table 84. Biovista Inc. Recent Developments/Updates

Table 85. Cardero Therapeutics Inc Company Information

Table 86. Cardero Therapeutics Inc Description and Business Overview

Table 87. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Cardero Therapeutics Inc Friedreich Ataxia Drug Product

Table 89. Cardero Therapeutics Inc Recent Developments/Updates

Table 90. Catabasis Pharmaceuticals, Inc. Company Information

Table 91. Catabasis Pharmaceuticals, Inc. Description and Business Overview

Table 92. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product

Table 94. Catabasis Pharmaceuticals, Inc. Recent Developments/Updates

Table 95. Forward Pharma A/S Company Information

Table 96. Forward Pharma A/S Description and Business Overview

Table 97. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Forward Pharma A/S Friedreich Ataxia Drug Product

Table 99. Forward Pharma A/S Recent Developments/Updates

Table 100. Ixchel Pharma LLC Company Information

Table 101. Ixchel Pharma LLC Description and Business Overview

Table 102. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Ixchel Pharma LLC Friedreich Ataxia Drug Product

Table 104. Ixchel Pharma LLC Recent Developments/Updates

Table 105. Pfizer Inc Company Information

Table 106. Pfizer Inc Description and Business Overview

Table 107. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Pfizer Inc Friedreich Ataxia Drug Product

Table 109. Pfizer Inc Recent Developments/Updates

Table 110. ProQR Therapeutics NV Company Information

Table 111. ProQR Therapeutics NV Description and Business Overview

Table 112. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. ProQR Therapeutics NV Friedreich Ataxia Drug Product

Table 114. ProQR Therapeutics NV Recent Developments/Updates

Table 115. RaNA Therapeutics Inc Company Information

Table 116. RaNA Therapeutics Inc Description and Business Overview

Table 117. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. RaNA Therapeutics Inc Friedreich Ataxia Drug Product

Table 119. RaNA Therapeutics Inc Recent Developments/Updates

Table 120. Reata Pharmaceuticals Inc Company Information

Table 121. Reata Pharmaceuticals Inc Description and Business Overview

Table 122. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 123. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product

Table 124. Reata Pharmaceuticals Inc Recent Developments/Updates

Table 125. Retrotope Inc Company Information

Table 126. Retrotope Inc Description and Business Overview

Table 127. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 128. Retrotope Inc Friedreich Ataxia Drug Product

Table 129. Retrotope Inc Recent Developments/Updates

Table 130. Takeda Company Information

Table 131. Takeda Description and Business Overview

Table 132. Takeda Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 133. Takeda Friedreich Ataxia Drug Product

Table 134. Takeda Recent Developments/Updates

Table 135. STATegics Inc Company Information

Table 136. STATegics Inc Description and Business Overview

Table 137. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 138. STATegics Inc Friedreich Ataxia Drug Product

Table 139. STATegics Inc Recent Developments/Updates

Table 140. Voyager Therapeutics Inc Company Information

Table 141. Voyager Therapeutics Inc Description and Business Overview

Table 142. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 143. Voyager Therapeutics Inc Friedreich Ataxia Drug Product

Table 144. Voyager Therapeutics Inc Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Friedreich Ataxia Drug Distributors List

Table 148. Friedreich Ataxia Drug Customers List

Table 149. Friedreich Ataxia Drug Market Trends

Table 150. Friedreich Ataxia Drug Market Drivers

Table 151. Friedreich Ataxia Drug Market Challenges

Table 152. Friedreich Ataxia Drug Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Friedreich Ataxia Drug

Figure 2. Global Friedreich Ataxia Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Friedreich Ataxia Drug Market Share by Type: 2024 & 2031

Figure 4. ADVM-063 Product Picture

Figure 5. AGIL-FA Product Picture

Figure 6. BHV-4157 Product Picture

Figure 7. BVA-202 Product Picture

Figure 8. Others Product Picture

Figure 9. Global Friedreich Ataxia Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Friedreich Ataxia Drug Market Share by Application: 2024 & 2031

Figure 11. Clinic

Figure 12. Hospital

Figure 13. Others

Figure 14. Global Friedreich Ataxia Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Friedreich Ataxia Drug Market Size (2020-2031) & (US$ Million)

Figure 16. Global Friedreich Ataxia Drug Sales (2020-2031) & (K Pcs)

Figure 17. Global Friedreich Ataxia Drug Average Price (USD/Pcs) & (2020-2031)

Figure 18. Friedreich Ataxia Drug Report Years Considered

Figure 19. Friedreich Ataxia Drug Sales Share by Manufacturers in 2024

Figure 20. Global Friedreich Ataxia Drug Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Friedreich Ataxia Drug Players: Market Share by Revenue in Friedreich Ataxia Drug in 2024

Figure 22. Friedreich Ataxia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Friedreich Ataxia Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Friedreich Ataxia Drug Sales Market Share by Country (2020-2031)

Figure 25. North America Friedreich Ataxia Drug Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Friedreich Ataxia Drug Sales Market Share by Country (2020-2031)

Figure 29. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2020-2031)

Figure 30. Germany Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Friedreich Ataxia Drug Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Friedreich Ataxia Drug Revenue Market Share by Region (2020-2031)

Figure 37. China Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Friedreich Ataxia Drug Sales Market Share by Country (2020-2031)

Figure 48. Latin America Friedreich Ataxia Drug Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Friedreich Ataxia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Friedreich Ataxia Drug by Type (2020-2031)

Figure 58. Global Revenue Market Share of Friedreich Ataxia Drug by Type (2020-2031)

Figure 59. Global Friedreich Ataxia Drug Price (USD/Pcs) by Type (2020-2031)

Figure 60. Global Sales Market Share of Friedreich Ataxia Drug by Application (2020-2031)

Figure 61. Global Revenue Market Share of Friedreich Ataxia Drug by Application (2020-2031)

Figure 62. Global Friedreich Ataxia Drug Price (USD/Pcs) by Application (2020-2031)

Figure 63. Friedreich Ataxia Drug Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions